Header Logo

Connection

Alan Go to Humans

This is a "connection" page, showing publications Alan Go has written about Humans.
Connection Strength

7.662
  1. CKD stage-specific utility of two equations for predicting 1-year risk of ESKD. PLoS One. 2023; 18(11):e0293293.
    View in: PubMed
    Score: 0.065
  2. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism. JAMA Netw Open. 2023 08 01; 6(8):e2328033.
    View in: PubMed
    Score: 0.064
  3. Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart Failure. Med Care. 2023 05 01; 61(5):268-278.
    View in: PubMed
    Score: 0.062
  4. Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community-Based Population. J Am Heart Assoc. 2023 03 21; 12(6):e028290.
    View in: PubMed
    Score: 0.062
  5. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023 03 01; 6(3):e232338.
    View in: PubMed
    Score: 0.062
  6. Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 2023 Mar; 54(3):e75-e85.
    View in: PubMed
    Score: 0.062
  7. Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis. Am Heart J. 2023 02; 256:60-72.
    View in: PubMed
    Score: 0.061
  8. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity. Am J Med. 2022 12; 135(12):1468-1477.
    View in: PubMed
    Score: 0.060
  9. The race coefficient in glomerular filtration rate-estimating equations and its removal. Curr Opin Nephrol Hypertens. 2022 11 01; 31(6):527-533.
    View in: PubMed
    Score: 0.060
  10. Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding. J Thromb Thrombolysis. 2022 Oct; 54(3):470-479.
    View in: PubMed
    Score: 0.060
  11. Effect of Medically Tailored Meals on Clinical Outcomes in Recently Hospitalized High-Risk Adults. Med Care. 2022 10 01; 60(10):750-758.
    View in: PubMed
    Score: 0.060
  12. Analysis of Worsening Heart Failure Events in an Integrated Health Care System. J Am Coll Cardiol. 2022 Jul 12; 80(2):111-122.
    View in: PubMed
    Score: 0.060
  13. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755.
    View in: PubMed
    Score: 0.058
  14. A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System. JAMA Netw Open. 2021 11 01; 4(11):e2135152.
    View in: PubMed
    Score: 0.057
  15. Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study. PLoS One. 2021; 16(10):e0257674.
    View in: PubMed
    Score: 0.057
  16. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
    View in: PubMed
    Score: 0.057
  17. Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges. JAMA. 2021 07 06; 326(1):82-84.
    View in: PubMed
    Score: 0.056
  18. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
    View in: PubMed
    Score: 0.054
  19. Implication of Trends in Timing of Dialysis Initiation for Incidence of End-stage Kidney Disease. JAMA Intern Med. 2020 12 01; 180(12):1647-1654.
    View in: PubMed
    Score: 0.053
  20. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
    View in: PubMed
    Score: 0.053
  21. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e006553.
    View in: PubMed
    Score: 0.053
  22. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e006415.
    View in: PubMed
    Score: 0.052
  23. Community-Based Epidemiology of Hospitalized Acute Kidney Injury. Pediatrics. 2020 09; 146(3).
    View in: PubMed
    Score: 0.052
  24. How much can we trust electronic health record data? Healthc (Amst). 2020 Sep; 8(3):100444.
    View in: PubMed
    Score: 0.052
  25. Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2020 06 09; 141(23):1915-1926.
    View in: PubMed
    Score: 0.052
  26. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020 08 13; 383(7):691-693.
    View in: PubMed
    Score: 0.051
  27. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc. 2020 03 17; 9(6):e014415.
    View in: PubMed
    Score: 0.051
  28. Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study. BMC Endocr Disord. 2020 Feb 19; 20(1):25.
    View in: PubMed
    Score: 0.050
  29. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI. Clin J Am Soc Nephrol. 2020 01 07; 15(1):26-34.
    View in: PubMed
    Score: 0.050
  30. Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications. Am J Cardiol. 2020 02 15; 125(4):553-561.
    View in: PubMed
    Score: 0.050
  31. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.050
  32. Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study. Am J Med. 2019 12; 132(12):1450-1457.e1.
    View in: PubMed
    Score: 0.048
  33. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med. 2018 03 01; 178(3):390-398.
    View in: PubMed
    Score: 0.044
  34. Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department. West J Emerg Med. 2018 Mar; 19(2):346-360.
    View in: PubMed
    Score: 0.044
  35. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care. 2017 12; 55(12):e137-e143.
    View in: PubMed
    Score: 0.043
  36. Short-Term Outcomes and Factors Associated With Adverse Events Among Adults Discharged From the Emergency Department After Treatment for Acute Heart Failure. Circ Heart Fail. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.043
  37. Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study. Ann Intern Med. 2017 Dec 19; 167(12):845-854.
    View in: PubMed
    Score: 0.043
  38. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
    View in: PubMed
    Score: 0.043
  39. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.042
  40. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.040
  41. Community-Based Trends in Acute Myocardial Infarction From 2008 to 2014. J Am Coll Cardiol. 2016 08 09; 68(6):666-668.
    View in: PubMed
    Score: 0.040
  42. Cardiovascular Disease Consequences of CKD. Semin Nephrol. 2016 07; 36(4):293-304.
    View in: PubMed
    Score: 0.039
  43. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.039
  44. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. 2016 Apr; 54(4):365-72.
    View in: PubMed
    Score: 0.039
  45. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 08 01; 102(15):1177-82.
    View in: PubMed
    Score: 0.039
  46. Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring. BMC Cardiovasc Disord. 2016 Feb 17; 16:35.
    View in: PubMed
    Score: 0.038
  47. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens. 2016 Feb; 34(2):244-52.
    View in: PubMed
    Score: 0.038
  48. Elevated BP after AKI. J Am Soc Nephrol. 2016 Mar; 27(3):914-23.
    View in: PubMed
    Score: 0.037
  49. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. JAMA Intern Med. 2015 Jun; 175(6):1060-2.
    View in: PubMed
    Score: 0.036
  50. Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2015 May; 47(5):e193-8.
    View in: PubMed
    Score: 0.036
  51. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015 Apr 14; 65(14):1411-20.
    View in: PubMed
    Score: 0.036
  52. Age, sex, and racial influences on the Beckman Coulter AccuTnI+3 99th percentile. Clin Chim Acta. 2015 Apr 15; 444:149-53.
    View in: PubMed
    Score: 0.036
  53. Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients. J Am Coll Cardiol. 2014 Dec 23; 64(24):2712.
    View in: PubMed
    Score: 0.035
  54. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58.
    View in: PubMed
    Score: 0.035
  55. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015 Jan; 169(1):149-54.
    View in: PubMed
    Score: 0.035
  56. Incident atrial fibrillation and risk of death in adults with chronic kidney disease. J Am Heart Assoc. 2014 Oct 20; 3(5):e001303.
    View in: PubMed
    Score: 0.035
  57. Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014 Sep 09; 64(10):985-94.
    View in: PubMed
    Score: 0.035
  58. The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease. Clin Cardiol. 2014 Sep; 37(9):546-51.
    View in: PubMed
    Score: 0.034
  59. Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study. JACC Cardiovasc Imaging. 2014 Jul; 7(7):690-700.
    View in: PubMed
    Score: 0.034
  60. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014 Oct; 25(10):2327-34.
    View in: PubMed
    Score: 0.034
  61. Intersection of cardiovascular disease and kidney disease: atrial fibrillation. Curr Opin Nephrol Hypertens. 2014 May; 23(3):275-82.
    View in: PubMed
    Score: 0.034
  62. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
    View in: PubMed
    Score: 0.033
  63. Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease. Perm J. 2014; 18(3):11-6.
    View in: PubMed
    Score: 0.033
  64. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):e28-e292.
    View in: PubMed
    Score: 0.033
  65. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014 Apr; 63(4):878-85.
    View in: PubMed
    Score: 0.033
  66. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014 Apr 01; 63(12):1230-1238.
    View in: PubMed
    Score: 0.033
  67. Incremental prognostic information from kidney function in patients with new onset coronary heart disease. Am Heart J. 2014 Jan; 167(1):86-92.
    View in: PubMed
    Score: 0.033
  68. Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. J Am Coll Cardiol. 2014 Jan 7-14; 63(1):33-9.
    View in: PubMed
    Score: 0.032
  69. Effectiveness and safety of spironolactone for systolic heart failure. Am J Cardiol. 2013 Nov 01; 112(9):1427-32.
    View in: PubMed
    Score: 0.032
  70. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):525-33.
    View in: PubMed
    Score: 0.032
  71. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013 Aug 21; 310(7):699-705.
    View in: PubMed
    Score: 0.032
  72. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013 Jun 21; 2(3):e000250.
    View in: PubMed
    Score: 0.032
  73. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
    View in: PubMed
    Score: 0.032
  74. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med. 2013 May 21; 158(10):727-34.
    View in: PubMed
    Score: 0.032
  75. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
    View in: PubMed
    Score: 0.031
  76. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J. 2013 May; 165(5):800-8, 808.e1-2.
    View in: PubMed
    Score: 0.031
  77. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2013 Apr; 121(4):879-80.
    View in: PubMed
    Score: 0.031
  78. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
    View in: PubMed
    Score: 0.031
  79. Effectiveness of ß-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail. 2013 Mar; 19(3):176-82.
    View in: PubMed
    Score: 0.031
  80. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):143-52.
    View in: PubMed
    Score: 0.031
  81. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 05; 127(5):569-74.
    View in: PubMed
    Score: 0.031
  82. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
    View in: PubMed
    Score: 0.031
  83. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jan 22; 61(3):295-301.
    View in: PubMed
    Score: 0.031
  84. Targeted maximum likelihood estimation for prediction calibration. Int J Biostat. 2012 Oct 31; 8(1):30.
    View in: PubMed
    Score: 0.030
  85. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012 Oct; 43(10):2788-90.
    View in: PubMed
    Score: 0.030
  86. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
    View in: PubMed
    Score: 0.028
  87. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011 Sep 14; 12:44.
    View in: PubMed
    Score: 0.028
  88. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011 Sep; 118(3):583-91.
    View in: PubMed
    Score: 0.028
  89. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011 Jun 24; 9:78.
    View in: PubMed
    Score: 0.028
  90. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.027
  91. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):248-56.
    View in: PubMed
    Score: 0.026
  92. CHA2DS2-VASc risk scheme: not ready for clinical use. Chest. 2010 Oct; 138(4):1020; author reply 1020-1.
    View in: PubMed
    Score: 0.026
  93. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010 Aug 27; 11:22.
    View in: PubMed
    Score: 0.026
  94. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10; 362(23):2155-65.
    View in: PubMed
    Score: 0.026
  95. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10; 170(9):759-64.
    View in: PubMed
    Score: 0.026
  96. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Arch Intern Med. 2009 Nov 23; 169(21):2032; author reply 2033.
    View in: PubMed
    Score: 0.025
  97. Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol. 2010 Feb; 21(2):374-80.
    View in: PubMed
    Score: 0.025
  98. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 01; 151(5):297-305.
    View in: PubMed
    Score: 0.024
  99. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):297-304.
    View in: PubMed
    Score: 0.024
  100. The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation. N Engl J Med. 2009 May 14; 360(20):2127-9.
    View in: PubMed
    Score: 0.024
  101. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009 May; 4(5):891-8.
    View in: PubMed
    Score: 0.024
  102. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9.
    View in: PubMed
    Score: 0.024
  103. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23; 169(4):342-50.
    View in: PubMed
    Score: 0.024
  104. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008 Dec 08; 168(22):2415-21.
    View in: PubMed
    Score: 0.023
  105. The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008 Nov; 1(2):138-47.
    View in: PubMed
    Score: 0.023
  106. Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther. 2008 Sep; 6(8):1043-5.
    View in: PubMed
    Score: 0.023
  107. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1487-93.
    View in: PubMed
    Score: 0.023
  108. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke. 2008 Jun; 39(6):1901-10.
    View in: PubMed
    Score: 0.022
  109. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Jul; 74(1):101-7.
    View in: PubMed
    Score: 0.022
  110. Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities. Contemp Clin Trials. 2008 Sep; 29(5):646-53.
    View in: PubMed
    Score: 0.022
  111. Stroke prevention in atrial fibrillation: another step sideways. Lancet. 2008 Jan 26; 371(9609):278-80.
    View in: PubMed
    Score: 0.022
  112. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation. CNS Drugs. 2008; 22(10):815-25.
    View in: PubMed
    Score: 0.022
  113. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J. 2007 Dec; 154(6):1035-42.
    View in: PubMed
    Score: 0.021
  114. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.021
  115. Community-based incidence of acute renal failure. Kidney Int. 2007 Jul; 72(2):208-12.
    View in: PubMed
    Score: 0.021
  116. Chronic kidney disease, anemia, and epoetin. N Engl J Med. 2007 Mar 01; 356(9):957; author reply 958-9.
    View in: PubMed
    Score: 0.021
  117. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.020
  118. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.020
  119. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006 Oct; 17(10):2892-9.
    View in: PubMed
    Score: 0.020
  120. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
    View in: PubMed
    Score: 0.020
  121. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006 May; 15(3):296-302.
    View in: PubMed
    Score: 0.019
  122. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
    View in: PubMed
    Score: 0.019
  123. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1357-63.
    View in: PubMed
    Score: 0.019
  124. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006 Jan 03; 144(1):21-8.
    View in: PubMed
    Score: 0.019
  125. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005 Nov; 68(5):2310-6.
    View in: PubMed
    Score: 0.019
  126. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20; 112(12):1687-91.
    View in: PubMed
    Score: 0.019
  127. Antithrombotic therapy for stroke prevention in atrial fibrillation. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):108-24.
    View in: PubMed
    Score: 0.019
  128. Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here? Nat Clin Pract Cardiovasc Med. 2005 May; 2(5):226-7.
    View in: PubMed
    Score: 0.018
  129. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr; 14(2):56-61.
    View in: PubMed
    Score: 0.018
  130. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 09 23; 351(13):1296-305.
    View in: PubMed
    Score: 0.017
  131. The importance of anticoagulation management services. Manag Care. 2004 Sep; 13(9 Suppl):20-5.
    View in: PubMed
    Score: 0.017
  132. Rationale and design of the KP ENRICH trial: A food is medicine intervention in low-income high-risk adults with diabetes within Kaiser Permanente. Contemp Clin Trials. 2024 Aug; 143:107601.
    View in: PubMed
    Score: 0.017
  133. Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKI. Clin J Am Soc Nephrol. 2024 Jul 01; 19(7):829-836.
    View in: PubMed
    Score: 0.017
  134. Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillation. J Am Coll Cardiol. 2004 Apr 07; 43(7):1225-7.
    View in: PubMed
    Score: 0.017
  135. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice. Am J Manag Care. 2004 Apr; 10(3 Suppl):S58-65.
    View in: PubMed
    Score: 0.017
  136. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004 Feb 04; 43(3):429-35.
    View in: PubMed
    Score: 0.017
  137. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003 Nov 26; 290(20):2685-92.
    View in: PubMed
    Score: 0.016
  138. Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system. BMC Cardiovasc Disord. 2023 11 21; 23(1):578.
    View in: PubMed
    Score: 0.016
  139. Proteomics of CKD progression in the chronic renal insufficiency cohort. Nat Commun. 2023 Oct 10; 14(1):6340.
    View in: PubMed
    Score: 0.016
  140. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction. J Am Heart Assoc. 2023 10 03; 12(19):e029736.
    View in: PubMed
    Score: 0.016
  141. Early Pregnancy Systolic Blood Pressure Patterns Predict Early- and Later-Onset Preeclampsia and Gestational Hypertension Among Ostensibly Low-to-Moderate Risk Groups. J Am Heart Assoc. 2023 08; 12(15):e029617.
    View in: PubMed
    Score: 0.016
  142. Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study. Ann Intern Med. 2023 07; 176(7):961-968.
    View in: PubMed
    Score: 0.016
  143. Proteomic cardiovascular risk assessment in chronic kidney disease. Eur Heart J. 2023 06 20; 44(23):2095-2110.
    View in: PubMed
    Score: 0.016
  144. Genome-wide Association Study for AKI. Kidney360. 2023 07 01; 4(7):870-880.
    View in: PubMed
    Score: 0.016
  145. The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease. Sci Rep. 2023 05 31; 13(1):8863.
    View in: PubMed
    Score: 0.016
  146. Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial. Circulation. 2023 06 20; 147(25):1891-1901.
    View in: PubMed
    Score: 0.016
  147. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients. J Lipid Res. 2023 Jun; 64(6):100381.
    View in: PubMed
    Score: 0.016
  148. Integrated Analysis of Blood and Urine Biomarkers to Identify Acute Kidney Injury Subphenotypes and Associations With Long-term Outcomes. Am J Kidney Dis. 2023 09; 82(3):311-321.e1.
    View in: PubMed
    Score: 0.016
  149. Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAF? trial). Trials. 2023 Mar 31; 24(1):246.
    View in: PubMed
    Score: 0.016
  150. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis. 2003 Feb; 15(1):41-6.
    View in: PubMed
    Score: 0.015
  151. Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health: A National Heart, Lung, and Blood Institute Workshop Report. JAMA Cardiol. 2023 Feb 01; 8(2):182-191.
    View in: PubMed
    Score: 0.015
  152. Predicting Cardiovascular Events after Sepsis with?Death as a Competing Risk. Ann Am Thorac Soc. 2023 01; 20(1):145-148.
    View in: PubMed
    Score: 0.015
  153. Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system. BMC Cardiovasc Disord. 2022 12 23; 22(1):566.
    View in: PubMed
    Score: 0.015
  154. The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results. PLoS One. 2022; 17(12):e0277961.
    View in: PubMed
    Score: 0.015
  155. Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA Study. JAMA Cardiol. 2022 11 01; 7(11):1160-1169.
    View in: PubMed
    Score: 0.015
  156. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.015
  157. Race, Interleukin-6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2022 09 20; 11(18):e025627.
    View in: PubMed
    Score: 0.015
  158. Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study. BMC Nephrol. 2022 09 13; 23(1):311.
    View in: PubMed
    Score: 0.015
  159. Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies. Am J Kidney Dis. 2023 02; 81(2):190-200.
    View in: PubMed
    Score: 0.015
  160. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thromb Res. 2022 Aug; 216:97-102.
    View in: PubMed
    Score: 0.015
  161. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race. JAMA. 2022 06 21; 327(23):2306-2316.
    View in: PubMed
    Score: 0.015
  162. Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction. J Am Heart Assoc. 2022 Jun 07; 11(11):e024913.
    View in: PubMed
    Score: 0.015
  163. Effect of Lifestyle Coaching or Enhanced Pharmacotherapy on Blood Pressure Control Among Black Adults With Persistent Uncontrolled Hypertension: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022 05 02; 5(5):e2212397.
    View in: PubMed
    Score: 0.015
  164. ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor. Am Heart J. 2022 07; 249:76-85.
    View in: PubMed
    Score: 0.015
  165. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 Apr 05; 11(7):e022891.
    View in: PubMed
    Score: 0.015
  166. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD. Kidney360. 2022 05 26; 3(5):859-871.
    View in: PubMed
    Score: 0.015
  167. Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic. Clin Cardiol. 2022 Feb; 45(2):180-188.
    View in: PubMed
    Score: 0.014
  168. Change in ankle-brachial index and mortality among individuals with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2021 12 02; 36(12):2224-2231.
    View in: PubMed
    Score: 0.014
  169. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
    View in: PubMed
    Score: 0.014
  170. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. N Engl J Med. 2021 11 04; 385(19):1750-1760.
    View in: PubMed
    Score: 0.014
  171. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 09; 285(18):2370-5.
    View in: PubMed
    Score: 0.014
  172. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study. Am J Kidney Dis. 2021 08; 78(2):200-209.e1.
    View in: PubMed
    Score: 0.014
  173. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med. 2001 Feb; 17(1):131-47.
    View in: PubMed
    Score: 0.013
  174. Biomarkers of inflammation and repair in kidney disease progression. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.013
  175. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 08; 78(2):226-235.e1.
    View in: PubMed
    Score: 0.013
  176. Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD. Am J Kidney Dis. 2021 06; 77(6):941-950.e1.
    View in: PubMed
    Score: 0.013
  177. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
    View in: PubMed
    Score: 0.013
  178. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):263-272.
    View in: PubMed
    Score: 0.013
  179. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021 02; 99(2):456-465.
    View in: PubMed
    Score: 0.013
  180. Neighborhood socioeconomic status and risk of hospitalization in patients with chronic kidney disease: A chronic renal insufficiency cohort study. Medicine (Baltimore). 2020 Jul 10; 99(28):e21028.
    View in: PubMed
    Score: 0.013
  181. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000 Jul 04; 102(1):11-3.
    View in: PubMed
    Score: 0.013
  182. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
    View in: PubMed
    Score: 0.013
  183. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 02; 105(2):246-252.
    View in: PubMed
    Score: 0.013
  184. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2020 08; 226:85-93.
    View in: PubMed
    Score: 0.013
  185. Association Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical Outcomes. JAMA Netw Open. 2020 04 01; 3(4):e202682.
    View in: PubMed
    Score: 0.013
  186. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
    View in: PubMed
    Score: 0.013
  187. Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study. Thromb Res. 2020 05; 189:112-118.
    View in: PubMed
    Score: 0.013
  188. Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. JAMA Intern Med. 2020 03 01; 180(3):402-410.
    View in: PubMed
    Score: 0.013
  189. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000 Feb 15; 108(3):216-26.
    View in: PubMed
    Score: 0.013
  190. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999 Dec 21; 131(12):927-34.
    View in: PubMed
    Score: 0.012
  191. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
    View in: PubMed
    Score: 0.012
  192. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286.
    View in: PubMed
    Score: 0.012
  193. Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2020 02 11; 141(6):482-492.
    View in: PubMed
    Score: 0.012
  194. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.012
  195. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
    View in: PubMed
    Score: 0.012
  196. Serum Calcification Propensity and Clinical Events in CKD. Clin J Am Soc Nephrol. 2019 11 07; 14(11):1562-1571.
    View in: PubMed
    Score: 0.012
  197. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc. 2019 11 05; 8(21):e012336.
    View in: PubMed
    Score: 0.012
  198. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study. Clin Chem. 2019 11; 65(11):1448-1457.
    View in: PubMed
    Score: 0.012
  199. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. Am J Kidney Dis. 2019 12; 74(6):771-781.
    View in: PubMed
    Score: 0.012
  200. Transition From Heart Disease to Cancer as the Leading Cause of Death in the United States. Ann Intern Med. 2019 08 06; 171(3):225.
    View in: PubMed
    Score: 0.012
  201. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
    View in: PubMed
    Score: 0.012
  202. Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. J Am Soc Nephrol. 2019 07; 30(7):1271-1281.
    View in: PubMed
    Score: 0.012
  203. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol. 2019 06 04; 73(21):2691-2700.
    View in: PubMed
    Score: 0.012
  204. Evidence supporting antileukotriene agents for asthma. JAMA. 1999 May 12; 281(18):1694.
    View in: PubMed
    Score: 0.012
  205. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
    View in: PubMed
    Score: 0.012
  206. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med. 1998 Nov 01; 129(9):690-7.
    View in: PubMed
    Score: 0.012
  207. Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. J Thromb Thrombolysis. 2018 Nov; 46(4):435-439.
    View in: PubMed
    Score: 0.012
  208. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
    View in: PubMed
    Score: 0.011
  209. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018 04; 93(4):968-976.
    View in: PubMed
    Score: 0.011
  210. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
    View in: PubMed
    Score: 0.011
  211. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11).
    View in: PubMed
    Score: 0.011
  212. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335.
    View in: PubMed
    Score: 0.011
  213. Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Arterioscler Thromb Vasc Biol. 2017 10; 37(10):1971-1978.
    View in: PubMed
    Score: 0.011
  214. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1795-1803.
    View in: PubMed
    Score: 0.011
  215. Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. Am J Hypertens. 2017 Aug 01; 30(8):822-829.
    View in: PubMed
    Score: 0.011
  216. Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017 07 18; 17(1):192.
    View in: PubMed
    Score: 0.011
  217. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017 08; 70(2):435-443.
    View in: PubMed
    Score: 0.011
  218. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes. 2017 07 01; 3(3):192-197.
    View in: PubMed
    Score: 0.011
  219. Research Priorities to Advance the Health and Health Care of Older Adults with Multiple Chronic Conditions. J Am Geriatr Soc. 2017 Jul; 65(7):1549-1553.
    View in: PubMed
    Score: 0.010
  220. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751.
    View in: PubMed
    Score: 0.010
  221. Health Literacy and Awareness of Atrial Fibrillation. J Am Heart Assoc. 2017 Apr 11; 6(4).
    View in: PubMed
    Score: 0.010
  222. Inflammation and Arterial Stiffness in Chronic Kidney Disease: Findings From the CRIC Study. Am J Hypertens. 2017 Apr 01; 30(4):400-408.
    View in: PubMed
    Score: 0.010
  223. Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
    View in: PubMed
    Score: 0.010
  224. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
    View in: PubMed
    Score: 0.010
  225. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
    View in: PubMed
    Score: 0.010
  226. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. J Am Geriatr Soc. 2017 Feb; 65(2):241-248.
    View in: PubMed
    Score: 0.010
  227. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
    View in: PubMed
    Score: 0.010
  228. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2017 01; 65(1):35-41.
    View in: PubMed
    Score: 0.010
  229. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017 01 06; 12(1):60-68.
    View in: PubMed
    Score: 0.010
  230. Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study. PLoS One. 2016; 11(10):e0164832.
    View in: PubMed
    Score: 0.010
  231. Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN). Am J Med. 2017 Mar; 130(3):317-327.
    View in: PubMed
    Score: 0.010
  232. Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. Circulation. 2016 10 11; 134(15):1122-1124.
    View in: PubMed
    Score: 0.010
  233. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int. 2016 12; 90(6):1348-1356.
    View in: PubMed
    Score: 0.010
  234. Research Needs to Improve Hypertension Treatment and Control in African Americans. Hypertension. 2016 11; 68(5):1066-1072.
    View in: PubMed
    Score: 0.010
  235. Measurement Error as Alternative Explanation for the Observation that CrCl/GFR Ratio is Higher at Lower GFR. Clin J Am Soc Nephrol. 2016 09 07; 11(9):1574-81.
    View in: PubMed
    Score: 0.010
  236. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56.
    View in: PubMed
    Score: 0.010
  237. Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals. JAMA Cardiol. 2016 08 01; 1(5):594-9.
    View in: PubMed
    Score: 0.010
  238. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Heart Assoc. 2016 07 22; 5(7).
    View in: PubMed
    Score: 0.010
  239. Inflammation and Progression of CKD: The CRIC Study. Clin J Am Soc Nephrol. 2016 09 07; 11(9):1546-56.
    View in: PubMed
    Score: 0.010
  240. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol. 2016 09 01; 118(5):697-9.
    View in: PubMed
    Score: 0.010
  241. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 06; 9(6).
    View in: PubMed
    Score: 0.010
  242. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis. 2016 Oct; 68(4):545-553.
    View in: PubMed
    Score: 0.010
  243. CKD Progression and Mortality among Hispanics and Non-Hispanics. J Am Soc Nephrol. 2016 Nov; 27(11):3488-3497.
    View in: PubMed
    Score: 0.010
  244. Multimorbidity is strongly associated with long-term but not short-term mortality after cardiac valve replacement. Int J Cardiol. 2016 Jul 15; 215:417-21.
    View in: PubMed
    Score: 0.010
  245. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016 07 07; 11(7):1189-96.
    View in: PubMed
    Score: 0.010
  246. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research. Circulation. 2016 Apr 05; 133(14):1410-8.
    View in: PubMed
    Score: 0.010
  247. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016 10; 31(10):1662-9.
    View in: PubMed
    Score: 0.010
  248. Cognitive Impairment and Progression of CKD. Am J Kidney Dis. 2016 Jul; 68(1):77-83.
    View in: PubMed
    Score: 0.010
  249. Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation. Eur Heart J. 2016 Nov 07; 37(42):3203-3210.
    View in: PubMed
    Score: 0.010
  250. Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease. Am J Cardiol. 2016 May 15; 117(10):1596-1603.
    View in: PubMed
    Score: 0.010
  251. Association of Age to Mortality and Repeat Revascularization in End-Stage Renal Disease Patients: Implications for Clinicians and Future Health Policies. Perm J. 2016; 20(2):4-9.
    View in: PubMed
    Score: 0.010
  252. Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2016; 11(2):e0148189.
    View in: PubMed
    Score: 0.010
  253. Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. J Hosp Med. 2016 06; 11(6):432-4.
    View in: PubMed
    Score: 0.010
  254. Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2016 08; 68(2):193-202.
    View in: PubMed
    Score: 0.010
  255. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol. 2016 Jan 28; 17:13.
    View in: PubMed
    Score: 0.010
  256. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47.
    View in: PubMed
    Score: 0.010
  257. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54.
    View in: PubMed
    Score: 0.010
  258. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med. 2016 06; 129(6):592-599.e1.
    View in: PubMed
    Score: 0.010
  259. Cardiac outcomes after regional or general anesthesia. Do we have the answer? Anesthesiology. 1996 Jan; 84(1):1-2.
    View in: PubMed
    Score: 0.009
  260. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25.
    View in: PubMed
    Score: 0.009
  261. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016 Apr; 174:29-36.
    View in: PubMed
    Score: 0.009
  262. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-360.
    View in: PubMed
    Score: 0.009
  263. Gastrointestinal symptoms, inflammation and hypoalbuminemia in chronic kidney disease patients: a cross-sectional study. BMC Nephrol. 2015 Dec 11; 16:211.
    View in: PubMed
    Score: 0.009
  264. Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol. 2016 Jul; 27(7):2196-204.
    View in: PubMed
    Score: 0.009
  265. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thromb Res. 2016 Jan; 137:97-102.
    View in: PubMed
    Score: 0.009
  266. Anticoagulation in atrial fibrillation: impact of mental illness. Am J Manag Care. 2015 Nov 01; 21(11):e609-17.
    View in: PubMed
    Score: 0.009
  267. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res. 2015 Dec; 136(6):1160-4.
    View in: PubMed
    Score: 0.009
  268. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet. 2015 Oct; 11(10):e1005378.
    View in: PubMed
    Score: 0.009
  269. Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1757-66.
    View in: PubMed
    Score: 0.009
  270. Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course. Circ Cardiovasc Genet. 2015 Dec; 8(6):803-11.
    View in: PubMed
    Score: 0.009
  271. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant. 2015 Dec; 50(12):1519-25.
    View in: PubMed
    Score: 0.009
  272. The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease. Circulation. 2015 Nov 24; 132(21):1999-2011.
    View in: PubMed
    Score: 0.009
  273. Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl. Am J Cardiol. 2015 Dec 01; 116(11):1700-4.
    View in: PubMed
    Score: 0.009
  274. Getting it Straight: Avoiding Blunders While Criticizing a Peer's Work. Int J Epidemiol. 2016 06; 45(3):619-20.
    View in: PubMed
    Score: 0.009
  275. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83.
    View in: PubMed
    Score: 0.009
  276. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Nov; 128(11):1252.e1-1252.e11.
    View in: PubMed
    Score: 0.009
  277. Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD. J Am Soc Nephrol. 2016 Feb; 27(2):559-69.
    View in: PubMed
    Score: 0.009
  278. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
    View in: PubMed
    Score: 0.009
  279. Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):393-402.
    View in: PubMed
    Score: 0.009
  280. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
    View in: PubMed
    Score: 0.009
  281. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
    View in: PubMed
    Score: 0.009
  282. Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization. Am Heart J. 2015 Aug; 170(2):400-8.
    View in: PubMed
    Score: 0.009
  283. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015 Sep; 30(9):1534-41.
    View in: PubMed
    Score: 0.009
  284. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1.
    View in: PubMed
    Score: 0.009
  285. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Aug; 66(2):266-73.
    View in: PubMed
    Score: 0.009
  286. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015 Feb 12; 518(7538):187-196.
    View in: PubMed
    Score: 0.009
  287. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015 Feb 12; 518(7538):197-206.
    View in: PubMed
    Score: 0.009
  288. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
    View in: PubMed
    Score: 0.009
  289. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
    View in: PubMed
    Score: 0.009
  290. Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc. 2014 Dec 03; 3(6):e001097.
    View in: PubMed
    Score: 0.009
  291. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
    View in: PubMed
    Score: 0.009
  292. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 01; 115(1):40-6.
    View in: PubMed
    Score: 0.009
  293. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Feb; 65(2):267-74.
    View in: PubMed
    Score: 0.009
  294. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015 Jan; 65(1):93-100.
    View in: PubMed
    Score: 0.009
  295. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014 Nov; 46(11):1173-86.
    View in: PubMed
    Score: 0.009
  296. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2015 Apr; 26(4):946-56.
    View in: PubMed
    Score: 0.009
  297. Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2014 Sep; 62(9):1623-9.
    View in: PubMed
    Score: 0.009
  298. Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail. 2014 Sep; 7(5):709-16.
    View in: PubMed
    Score: 0.009
  299. ß-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol. 2014 Jul 22; 64(3):247-52.
    View in: PubMed
    Score: 0.009
  300. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6.
    View in: PubMed
    Score: 0.008
  301. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):596-601.
    View in: PubMed
    Score: 0.008
  302. Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry. Am Heart J. 2014 Aug; 168(2):160-7.
    View in: PubMed
    Score: 0.008
  303. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014 Jun 03; 63(21):2249-57.
    View in: PubMed
    Score: 0.008
  304. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circulation. 2014 May 20; 129(20):2005-12.
    View in: PubMed
    Score: 0.008
  305. Population trends from 2000-2011 in nuclear myocardial perfusion imaging use. JAMA. 2014 Mar 26; 311(12):1248-9.
    View in: PubMed
    Score: 0.008
  306. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
    Score: 0.008
  307. Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014 Mar 25; 82(12):1033-7.
    View in: PubMed
    Score: 0.008
  308. Lone atrial fibrillation: does it exist? J Am Coll Cardiol. 2014 May 06; 63(17):1715-23.
    View in: PubMed
    Score: 0.008
  309. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant. 2014 Apr; 29(4):864-72.
    View in: PubMed
    Score: 0.008
  310. Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study. BMC Nephrol. 2013 Dec 05; 14:268.
    View in: PubMed
    Score: 0.008
  311. Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study. Eur Heart J. 2014 Aug 14; 35(31):2115-22.
    View in: PubMed
    Score: 0.008
  312. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
    View in: PubMed
    Score: 0.008
  313. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb; 25(2):349-60.
    View in: PubMed
    Score: 0.008
  314. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013 Oct 22; 14:229.
    View in: PubMed
    Score: 0.008
  315. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.008
  316. Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. JACC Heart Fail. 2013 Oct; 1(5):445-53.
    View in: PubMed
    Score: 0.008
  317. Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". Circulation. 2013 Sep 10; 128(11):e172-3.
    View in: PubMed
    Score: 0.008
  318. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8.
    View in: PubMed
    Score: 0.008
  319. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013 Jul 10; 310(2):155-62.
    View in: PubMed
    Score: 0.008
  320. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):461-9.
    View in: PubMed
    Score: 0.008
  321. Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol. 2013 Aug 27; 62(9):789-98.
    View in: PubMed
    Score: 0.008
  322. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013 May 15; 309(19):2025-34.
    View in: PubMed
    Score: 0.008
  323. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
    View in: PubMed
    Score: 0.008
  324. Sex differences in cardiovascular outcomes in patients with incident hypertension. J Hypertens. 2013 Feb; 31(2):271-7.
    View in: PubMed
    Score: 0.008
  325. Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol. 2013 May 01; 111(9):1324-9.
    View in: PubMed
    Score: 0.008
  326. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Feb 01; 2(1):e005694.
    View in: PubMed
    Score: 0.008
  327. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. J Am Coll Cardiol. 2013 Mar 05; 61(9):957-70.
    View in: PubMed
    Score: 0.008
  328. Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis. 2013 May; 61(5):701-9.
    View in: PubMed
    Score: 0.008
  329. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013 Jan; 61(1):26-33.
    View in: PubMed
    Score: 0.008
  330. Validation of the Kidney Disease Quality of Life Short Form 36 (KDQOL-36) US Spanish and English versions in a cohort of Hispanics with chronic kidney disease. Ethn Dis. 2013; 23(2):202-9.
    View in: PubMed
    Score: 0.008
  331. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013 Jan 15; 127(2):224-32.
    View in: PubMed
    Score: 0.008
  332. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013 Jan; 45(1):25-33.
    View in: PubMed
    Score: 0.008
  333. Retinopathy and cognitive impairment in adults with CKD. Am J Kidney Dis. 2013 Feb; 61(2):219-27.
    View in: PubMed
    Score: 0.008
  334. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol. 2013 Feb 01; 111(3):432-8.
    View in: PubMed
    Score: 0.008
  335. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
    View in: PubMed
    Score: 0.008
  336. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012 Dec 15; 110(12):1735-41.
    View in: PubMed
    Score: 0.008
  337. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol. 2012 Sep; 130(9):1136-44.
    View in: PubMed
    Score: 0.008
  338. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
    View in: PubMed
    Score: 0.008
  339. Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials. 2012 Nov; 33(6):1238-44.
    View in: PubMed
    Score: 0.007
  340. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9.
    View in: PubMed
    Score: 0.007
  341. Pharmacotherapy in Medicare beneficiaries with atrial fibrillation. Heart Rhythm. 2012 Sep; 9(9):1403-8.
    View in: PubMed
    Score: 0.007
  342. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012 May; 7(5):844-50.
    View in: PubMed
    Score: 0.007
  343. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol. 2012 May; 7(5):856-60.
    View in: PubMed
    Score: 0.007
  344. Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol. 2012 May; 7(5):851-5.
    View in: PubMed
    Score: 0.007
  345. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e531S-e575S.
    View in: PubMed
    Score: 0.007
  346. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012 Jan 10; 59(2):143-9.
    View in: PubMed
    Score: 0.007
  347. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
    View in: PubMed
    Score: 0.007
  348. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:282-90.
    View in: PubMed
    Score: 0.007
  349. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.007
  350. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83.
    View in: PubMed
    Score: 0.007
  351. Ethnic differences in the development of albuminuria: the DISTANCE study. Am J Manag Care. 2011 Nov; 17(11):737-45.
    View in: PubMed
    Score: 0.007
  352. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011 Nov; 121(11):4393-408.
    View in: PubMed
    Score: 0.007
  353. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J. 2011 Oct; 162(4):606-612.e1.
    View in: PubMed
    Score: 0.007
  354. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011 Sep 11; 478(7367):103-9.
    View in: PubMed
    Score: 0.007
  355. Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2121-31.
    View in: PubMed
    Score: 0.007
  356. Mental illness and warfarin use in atrial fibrillation. Am J Manag Care. 2011 Sep; 17(9):617-24.
    View in: PubMed
    Score: 0.007
  357. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19; 58(4):395-401.
    View in: PubMed
    Score: 0.007
  358. Racial variation in lipoprotein-associated phospholipase A2 in older adults. BMC Cardiovasc Disord. 2011 Jun 29; 11:38.
    View in: PubMed
    Score: 0.007
  359. American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation. 2011 Jul 19; 124(3):363-72.
    View in: PubMed
    Score: 0.007
  360. CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis. 2011 Aug; 58(2):214-27.
    View in: PubMed
    Score: 0.007
  361. Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study. JACC Cardiovasc Imaging. 2011 Jun; 4(6):622-9.
    View in: PubMed
    Score: 0.007
  362. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31.
    View in: PubMed
    Score: 0.007
  363. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011 May; 161(5):979-85.
    View in: PubMed
    Score: 0.007
  364. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol. 2011; 33(6):477-84.
    View in: PubMed
    Score: 0.007
  365. Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure. J Card Fail. 2011 Jan; 17(1):17-23.
    View in: PubMed
    Score: 0.007
  366. Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson. 2010 Dec 30; 12:75.
    View in: PubMed
    Score: 0.007
  367. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.007
  368. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol. 2010 Nov 02; 56(19):1552-63.
    View in: PubMed
    Score: 0.007
  369. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11.
    View in: PubMed
    Score: 0.007
  370. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):624-31.
    View in: PubMed
    Score: 0.007
  371. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation. 2010 Oct 12; 122(15):1478-87.
    View in: PubMed
    Score: 0.007
  372. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension. 2010 Sep; 56(3):518-24.
    View in: PubMed
    Score: 0.006
  373. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010 Jun; 159(6):1102-7.
    View in: PubMed
    Score: 0.006
  374. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv. 2010 Jun 01; 3(3):230-5.
    View in: PubMed
    Score: 0.006
  375. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):261-6.
    View in: PubMed
    Score: 0.006
  376. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
    View in: PubMed
    Score: 0.006
  377. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):948-54.
    View in: PubMed
    Score: 0.006
  378. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010 Feb; 58(2):338-45.
    View in: PubMed
    Score: 0.006
  379. Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE). Am J Hematol. 2010 Jan; 85(1):57-61.
    View in: PubMed
    Score: 0.006
  380. Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health. 2010 Jan; 7(1):87-94.
    View in: PubMed
    Score: 0.006
  381. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int. 2010 Mar; 77(6):536-42.
    View in: PubMed
    Score: 0.006
  382. Characterizing the admixed African ancestry of African Americans. Genome Biol. 2009; 10(12):R141.
    View in: PubMed
    Score: 0.006
  383. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):e46-e215.
    View in: PubMed
    Score: 0.006
  384. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010 Mar; 23(3):282-9.
    View in: PubMed
    Score: 0.006
  385. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010 Jan; 56(1):111-20.
    View in: PubMed
    Score: 0.006
  386. Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers. Circ Cardiovasc Qual Outcomes. 2009 Nov; 2(6):663-70.
    View in: PubMed
    Score: 0.006
  387. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
    View in: PubMed
    Score: 0.006
  388. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009 Oct; 76(8):893-9.
    View in: PubMed
    Score: 0.006
  389. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1302-11.
    View in: PubMed
    Score: 0.006
  390. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.006
  391. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
    View in: PubMed
    Score: 0.006
  392. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009 May 05; 119(17):2408-16.
    View in: PubMed
    Score: 0.006
  393. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.006
  394. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 03; 119(4):606-18.
    View in: PubMed
    Score: 0.006
  395. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27; 119(3):480-6.
    View in: PubMed
    Score: 0.006
  396. Chronic kidney disease in United States Hispanics: a growing public health problem. Ethn Dis. 2009; 19(4):466-72.
    View in: PubMed
    Score: 0.006
  397. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27; 119(3):e21-181.
    View in: PubMed
    Score: 0.006
  398. Incidental pulmonary nodules on cardiac computed tomography: prognosis and use. Am J Med. 2008 Nov; 121(11):989-96.
    View in: PubMed
    Score: 0.006
  399. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):546S-592S.
    View in: PubMed
    Score: 0.006
  400. Chronic conditions and mortality among the oldest old. Am J Public Health. 2008 Jul; 98(7):1209-14.
    View in: PubMed
    Score: 0.006
  401. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet. 2008 Aug 01; 17(15):2320-8.
    View in: PubMed
    Score: 0.006
  402. Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Arch Intern Med. 2008 Apr 14; 168(7):756-61.
    View in: PubMed
    Score: 0.006
  403. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med Genet. 2008 Apr 02; 9:23.
    View in: PubMed
    Score: 0.006
  404. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008 May; 123(4):399-408.
    View in: PubMed
    Score: 0.006
  405. Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. JACC Cardiovasc Imaging. 2008 Mar; 1(2):167-73.
    View in: PubMed
    Score: 0.006
  406. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008 Feb 26; 51(8):810-5.
    View in: PubMed
    Score: 0.005
  407. ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration with the Heart Rhythm Society. J Am Coll Cardiol. 2008 Feb 26; 51(8):865-84.
    View in: PubMed
    Score: 0.005
  408. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation. 2008 Feb 26; 117(8):1101-20.
    View in: PubMed
    Score: 0.005
  409. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 Jan 29; 117(4):e25-146.
    View in: PubMed
    Score: 0.005
  410. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J. 2007 Dec; 154(6):1043-51.
    View in: PubMed
    Score: 0.005
  411. Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J. 2007 Dec; 154(6):1052-8.
    View in: PubMed
    Score: 0.005
  412. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J. 2007 Dec; 154(6):1059-64.
    View in: PubMed
    Score: 0.005
  413. Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007 Nov; 13(11):598-606.
    View in: PubMed
    Score: 0.005
  414. Patient sex and quality of ED care for patients with myocardial infarction. Am J Emerg Med. 2007 Nov; 25(9):996-1003.
    View in: PubMed
    Score: 0.005
  415. A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis. 2008 May; 198(1):136-44.
    View in: PubMed
    Score: 0.005
  416. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8.
    View in: PubMed
    Score: 0.005
  417. Correlation between pulse wave velocity and other measures of arterial stiffness in chronic kidney disease. Clin Nephrol. 2007 Sep; 68(3):133-43.
    View in: PubMed
    Score: 0.005
  418. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics. 2007 Nov 14; 31(3):402-9.
    View in: PubMed
    Score: 0.005
  419. Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years. Am J Cardiol. 2007 Sep 15; 100(6):981-5.
    View in: PubMed
    Score: 0.005
  420. Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev. 2007 Jul-Aug; 27(4):227-32.
    View in: PubMed
    Score: 0.005
  421. Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf. 2007 Jun; 16(6):620-6.
    View in: PubMed
    Score: 0.005
  422. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007 Aug; 120(8):700-5.
    View in: PubMed
    Score: 0.005
  423. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007 Sep; 17(9):669-78.
    View in: PubMed
    Score: 0.005
  424. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007 Feb 06; 115(5):e69-171.
    View in: PubMed
    Score: 0.005
  425. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.005
  426. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol. 2007 Jan; 2(1):81-8.
    View in: PubMed
    Score: 0.005
  427. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol. 2006 Nov 07; 48(9):1800-7.
    View in: PubMed
    Score: 0.005
  428. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc. 2006 Aug; 54(8):1231-6.
    View in: PubMed
    Score: 0.005
  429. Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol. 2006 Sep 15; 164(6):598-606.
    View in: PubMed
    Score: 0.005
  430. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation. 2006 Jul 11; 114(2):168-82.
    View in: PubMed
    Score: 0.005
  431. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005 Dec; 68(6):2801-8.
    View in: PubMed
    Score: 0.005
  432. Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. J Am Soc Nephrol. 2005 Dec; 16(12):3711-20.
    View in: PubMed
    Score: 0.005
  433. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL. Kidney Int. 2005 Aug; 68(2):788-95.
    View in: PubMed
    Score: 0.005
  434. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005 Sep; 16(9):2778-88.
    View in: PubMed
    Score: 0.005
  435. Older emergency department patients with acute myocardial infarction receive lower quality of care than younger patients. Ann Emerg Med. 2005 Jul; 46(1):14-21.
    View in: PubMed
    Score: 0.005
  436. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol. 2005 Jun; 32(6):1076-80.
    View in: PubMed
    Score: 0.005
  437. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005 Apr 25; 165(8):923-8.
    View in: PubMed
    Score: 0.005
  438. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
    View in: PubMed
    Score: 0.004
  439. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16; 141(10):745-52.
    View in: PubMed
    Score: 0.004
  440. Gender and risk of adverse outcomes in heart failure. Am J Cardiol. 2004 Nov 01; 94(9):1147-52.
    View in: PubMed
    Score: 0.004
  441. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004 Nov; 114(5):1206-11.
    View in: PubMed
    Score: 0.004
  442. Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf. 2004 Oct; 13(10):661-7.
    View in: PubMed
    Score: 0.004
  443. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):429S-456S.
    View in: PubMed
    Score: 0.004
  444. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol. 2004 Jul 21; 44(2):475-95.
    View in: PubMed
    Score: 0.004
  445. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation. 2004 Jun 29; 109(25):3223-43.
    View in: PubMed
    Score: 0.004
  446. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
    View in: PubMed
    Score: 0.004
  447. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003 Sep 22; 163(17):2052-7.
    View in: PubMed
    Score: 0.004
  448. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003 Sep 11; 349(11):1019-26.
    View in: PubMed
    Score: 0.004
  449. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003 Sep; 112(3 Pt 1):620-7.
    View in: PubMed
    Score: 0.004
  450. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
    View in: PubMed
    Score: 0.004
  451. Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol. 2002 Sep; 59(9):1437-41.
    View in: PubMed
    Score: 0.004
  452. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation. 2001 Nov 06; 104(19):2300-4.
    View in: PubMed
    Score: 0.004
  453. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol. 2001 Nov 01; 38(5):1297-301.
    View in: PubMed
    Score: 0.004
  454. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400.
    View in: PubMed
    Score: 0.004
  455. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail. 2001 Sep; 7(3):221-8.
    View in: PubMed
    Score: 0.004
  456. Factors affecting patients' self-referral to specialists. JAMA. 2001 Aug 08; 286(6):672-3.
    View in: PubMed
    Score: 0.003
  457. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001 Aug; 38(2):478-85.
    View in: PubMed
    Score: 0.003
  458. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7.
    View in: PubMed
    Score: 0.003
  459. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001 Jun 05; 103(22):2668-73.
    View in: PubMed
    Score: 0.003
  460. Overuse of administrative data to measure underuse of care. JAMA. 2001 Feb 14; 285(6):735; discussion 736-7.
    View in: PubMed
    Score: 0.003
  461. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol. 2000 Sep; 36(3):706-12.
    View in: PubMed
    Score: 0.003
  462. Prediction of risk for patients with unstable angina. Evid Rep Technol Assess (Summ). 2000 Aug; (31):1-3.
    View in: PubMed
    Score: 0.003
  463. Clinical symptoms and myocardial infarction in left bundle branch block patients. Cardiology. 2000; 93(1-2):100-4.
    View in: PubMed
    Score: 0.003
  464. Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? Arch Intern Med. 1999 Jul 12; 159(13):1429-36.
    View in: PubMed
    Score: 0.003
  465. Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction? JAMA. 1999 Feb 24; 281(8):714-9.
    View in: PubMed
    Score: 0.003
  466. Case Records of the Massachusetts General Hospital--a home-court advantage? N Engl J Med. 1995 Sep 28; 333(13):883-4.
    View in: PubMed
    Score: 0.002
  467. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol. 1990 Oct; 64(10):4735-42.
    View in: PubMed
    Score: 0.002

© 2024 Kaiser Permanente